Get Premium to unlock powerful stock data

Kahn Brothers Reduces Positions in Straight Path, New York Times, Hologic, Several Others

The fund's 7 largest 3rd-quarter sales

Author's Avatar
Nov 14, 2017
Article's Main Image

Investment firm

Kahn Brothers (Trades, Portfolio) was founded in 1978 by Irving Kahn, Thomas Graham Kahn and Alan Kahn. During the third quarter, the firm traded the following stocks:

The firm reduced its Straight Path Communications Inc. (

STRP, Financial) holding by 67.57%, impacting the portfolio by -3.2%.

ea376f190f1b3f9919569d2195877d70.png

The telecommunication company has a market cap of $2.3 billion and an enterprise value of $2.3 billion.

GuruFocus gives the company a profitability and growth rating of 5 out of 10. The return on capital (ROC) of -15,982.90% and return on assets (ROA) of -328.67% are underperforming 100% of companies in the Global Telecom Services industry. Financial strength has a rating of 4 out of 10. The cash-debt ratio of 0.76 is above the industry median of 0.37.

The company's largest shareholder among the gurus is Kahn Brothers with 0.44% of outstanding shares, followed by

Jim Simons  (Trades, Portfolio) with 0.27%,  Paul Tudor Jones (Trades, Portfolio) with 0.2%, Mario Gabelli (Trades, Portfolio) with 0.09% and Murray Stahl (Trades, Portfolio) with 0.02%.

The New York Times Co. (

NYT, Financial) position was reduced by 9.40%, impacting the portfolio by -0.87%.

39624ac051ca1d2c019e6e97121b0de4.png

The publishing company has a market cap of $2.79 billion and an enterprise value of $2.46 billion.

GuruFocus gives the company a profitability and growth rating of 5 out of 10. The return on equity (ROE) of 11.39% and ROA of 4.41% are outperforming 54% of companies in the Global Publishing industry. Financial strength has a rating of 7 out of 10. The cash-debt ratio of 2.33 is above the industry median of 1.58.

The firm is the company's largest guru shareholder with 2.17% of outstanding shares, followed by Simons with 1.25%, Barrow, Hanley, Mewhinney & Strauss with 0.29% and

Chuck Royce (Trades, Portfolio) with 0.19%.

The Hologic Inc. (

HOLX, Financial) position was trimmed 8.46%. The transaction had an impact of -0.47% on the portfolio.

32cba8a581acb7dc71b52bdb4b403be2.png

The diagnostic products manufacturer has a market cap of $11.09 billion and an enterprise value of $13.75 billion.

GuruFocus gives the company a profitability and growth rating of 6 out of 10. The ROE of 29.47% and ROA of 9.57% are outperforming 79% of companies in the Global Medical Instruments and Supplies industry. Financial strength has a rating of 5 out of 10. The cash-debt ratio of 0.16 is below the industry median of 1.69.

The 

Vanguard Health Care Fund (Trades, Portfolio) is the company's largest shareholder among the gurus with 1.25% of outstanding shares, followed by Simons with 0.44% and Jerome Dodson (Trades, Portfolio) with 0.26%.

The firm reduced its holding of Seaboard Corp. (

SEB, Financial) by 4.69%. The trade had an impact of -0.24% on the portfolio.

6d7b93729c34fb33070cbf43a5626a29.png

The agribusiness and transportation company has a market cap of $5.13 billion and an enterprise value of $4.36 billion.

GuruFocus gives the company a profitability and growth rating of 5 out of 10. The ROE of 10.12% and ROA of 6.80% are outperforming 78% of companies in the Global Conglomerates industry. Financial strength has a rating of 7 out of 10. The cash-debt ratio of 2.23 is below the industry median of 4.54.

Another notable guru shareholder is Simons with 0.45% of outstanding shares, followed by Jones with 0.02% and Stahl with 0.01%.

The firm curbed its Citigroup Inc. (

C, Financial) holding by 2.13%. The trade had an impact of -0.22% on the portfolio.

db3000a0e8dc84c785f8b2858e90b798.png

The bank has a market cap of $191.27 billion and an enterprise value of $296.22 billion.

GuruFocus gives the company a profitability and growth rating of 4 out of 10. The ROE of 6.24% and ROA of 0.85% are underperforming 69% of companies in the Global Banks – Global industry. Financial strength has a rating of 4 out of 10. The cash-debt ratio of 0.69 is below the industry median of 2.05.

With 0.62% of outstanding shares, Barrow, Hanley, Mewhinney & Strauss is the company's largest guru shareholder, followed by Hotchkis & Wiley with 0.55%,

First Pacific Advisors (Trades, Portfolio) with 0.42% and Bill Nygren (Trades, Portfolio) with 0.36%.

The GlaxoSmithKline PLC (

GSK, Financial) holding was curbed by 3.22%, impacting the portfolio by -0.22%.

113bcd89099e8ffee752643a2141b2de.png

The drug manufacturer has a market cap of $87.76 billion and an enterprise value of $111.72 billion.

GuruFocus gives the company a profitability and growth rating of 6 out of 10. While the ROE of 229.78% is outperforming the sector, the ROA of 3.97% is underperforming 57% of companies in the Global Drug Manufacturers - Major industry. Financial strength has a rating of 4 out of 10. The cash-debt ratio of 0.25 is below the industry median of 2.89.

The company's largest shareholder among the gurus is

Ken Fisher (Trades, Portfolio) with 0.52% of outstanding shares, followed by Simons with 0.38%, Hotchkis & Wiley with 0.32%, Charles Brandes (Trades, Portfolio) with 0.14% and NWQ Managers (Trades, Portfolio) with 0.1%.

The MBIA Inc. (

MBI, Financial) position was reduced by 3.28%. The trade had an impact of -0.21% on the portfolio.

5ee6ed763299c64f07d21e1be9a62699.png

The insurance company has a market cap of $815.91 million and an enterprise value of $3.14 billion.

GuruFocus gives the company a profitability and growth rating of 4 out of 10. The ROE of -66.65% and ROA of -17.21% are underperforming 99% of the companies in the Global Insurance - Property and Casualty industry. Financial strength has a rating of 3 out of 10. The cash-debt ratio of 0.05 is below the industry median of 3.15.

With 3.45% of outstanding shares, Kahn Brothers is the company's largest guru shareholder, followed by Royce with 3.07%,

Steven Cohen (Trades, Portfolio) with 1.14% and Francis Chou (Trades, Portfolio) with 0.86%.

Disclosure: I do not own any stocks mentioned in this article.

Also check out:
Rating:
0 / 5 (0 votes)

GuruFocus Screeners

Related Articles